Viridian Therapeutics Files 2024 10-K
Ticker: VRDN · Form: 10-K · Filed: Mar 3, 2025 · CIK: 1590750
Sentiment: neutral
Topics: 10-K, annual-report, biotechnology
TL;DR
Viridian Therapeutics filed its 2024 10-K, detailing financials for the year ending Dec 31, 2024.
AI Summary
Viridian Therapeutics, Inc. filed its 2024 10-K on March 3, 2025, reporting its fiscal year ended December 31, 2024. The company, formerly known as Miragen Therapeutics, Inc. and Signal Genetics, Inc., is incorporated in Delaware and headquartered in Waltham, MA. The filing covers its financial performance and business operations for the fiscal year 2024.
Why It Matters
This 10-K filing provides a comprehensive overview of Viridian Therapeutics' financial health and operational status for the fiscal year 2024, crucial for investors and stakeholders to assess the company's performance and future prospects.
Risk Assessment
Risk Level: medium — As a biotechnology company, Viridian Therapeutics is subject to inherent risks related to drug development, regulatory approvals, and market competition.
Key Players & Entities
- Viridian Therapeutics, Inc. (company) — Filer of the 10-K
- Miragen Therapeutics, Inc. (company) — Former company name
- Signal Genetics, Inc. (company) — Former company name
- 2024-12-31 (date) — Fiscal year end
- 2025-03-03 (date) — Filing date
- Waltham, MA (location) — Company headquarters
FAQ
What was Viridian Therapeutics' fiscal year end for this filing?
The fiscal year end for this filing was December 31, 2024.
When was this 10-K filing submitted to the SEC?
This 10-K filing was submitted on March 3, 2025.
What are the former names of Viridian Therapeutics, Inc. mentioned in the filing?
The filing mentions former names of Miragen Therapeutics, Inc. and Signal Genetics, Inc.
Where is Viridian Therapeutics, Inc. headquartered?
Viridian Therapeutics, Inc. is headquartered in Waltham, MA.
What is the Standard Industrial Classification (SIC) code for Viridian Therapeutics, Inc.?
The SIC code listed is 8071, which corresponds to SERVICES-MEDICAL LABORATORIES.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 3, 2025 regarding Viridian Therapeutics, Inc.\DE (VRDN).